DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2261452/why-alexandria-real-estate-equities-are-is-a-top-dividend-stock-for-your-portfolio?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-2261452 Apr 24, 2024 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out. 0

https://www.zacks.com/stock/news/2259673/here-s-what-key-metrics-tell-us-about-alexandria-real-estate-equities-are-q1-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2259673 Apr 22, 2024 - While the top- and bottom-line numbers for Alexandria Real Estate Equities (ARE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. 0

https://www.zacks.com/commentary/2257574/top-stock-reports-for-nvidia-alphabet-johnson-johnson?cid=CS-ZC-FT-research_daily-2257574 Apr 18, 2024 - Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Alphabet Inc. (GOOGL) and Johnson & Johnson (JNJ). 0

https://www.zacks.com/stock/news/2257870/sl-green-s-slg-q1-ffo-beat-estimates-24-ffo-view-raised?cid=CS-ZC-FT-analyst_blog|earnings_article-2257870 Apr 18, 2024 - SL Green's (SLG) Q1 FFO outshines estimates. However, rental revenues and the occupancy in Manhattan's same-store office portfolio fall year over year. 0

https://www.zacks.com/stock/news/2257051/alexandria-are-to-post-q1-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257051 Apr 17, 2024 - While Alexandria's (ARE) Q1 earnings are likely to have benefited from the healthy demand for its high-quality life science and lab office properties, high interest expenses raise concern. 0

https://www.zacks.com/stock/news/2254776/should-investors-retain-healthpeak-doc-stock-for-now?cid=CS-ZC-FT-analyst_blog|zer_report_update-2254776 Apr 12, 2024 - Solid demand for lab assets and rising healthcare expenditure by senior citizens bode well for Healthpeak (DOC). However, competition from peers and high interest rates are woes. 0

https://www.zacks.com/stock/news/2254744/here-s-why-alexandria-are-is-an-apt-portfolio-pick-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2254744 Apr 12, 2024 - Robust demand for Alexandria's (ARE) high-quality life science and lab office properties in key markets, healthy operating performance and expansion efforts bode well for long-term growth. 0

https://www.fool.com/investing/2024/03/28/bull-market-buys-3-dividend-stocks-to-own-for-the/?source=iedfolrf0000001 Mar 28, 2024 - Invest in stability, dividends, and growth with these three accomplished real estate operators. 0

https://www.zacks.com/stock/news/2245030/are-you-looking-for-a-high-growth-dividend-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-2245030 Mar 22, 2024 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out. 0

https://www.zacks.com/stock/news/2236844/why-alexandria-real-estate-equities-are-is-a-great-dividend-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-2236844 Mar 06, 2024 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out. 0